
How to Find the Right Medical Rehab Services
What kinds of rehab therapy might I need?
Physical therapy helps patients improve their strength, stability and movement and reduce pain, usually through targeted exercises. Some physical therapists specialize in neurological, cardiovascular or orthopedic issues. There are also geriatric and pediatric specialists. Occupational therapy focuses on specific activities (referred to as 'occupations'), often ones that require fine motor skills, like brushing teeth, cutting food with a knife and getting dressed. Speech and language therapy help people to communicate. Some patients may need respiratory therapy if they have trouble breathing or need to be weaned from a ventilator.
Will insurance cover rehab?
Medicare, health insurers, workers' compensation and Medicaid plans in some states cover rehab therapy, but plans may refuse to pay for certain settings and may limit the amount of therapy you receive. Some insurers may require preauthorization, and some may terminate coverage if you're not improving. Private insurers often place annual limits on outpatient therapy. Traditional Medicare is generally the least restrictive, while private Medicare Advantage plans may monitor progress closely and limit where patients can obtain therapy.
Should I seek inpatient rehabilitation?
Patients who still need nursing or a doctor's care but can tolerate three hours of therapy five days a week may qualify for admission to a specialized rehab hospital or to a unit within a general hospital. Patients usually need at least two of the main types of rehab therapy: physical, occupational or speech. Stays average around 12 days.
How do I choose?
Look for a place that is skilled in treating people with your diagnosis; many inpatient hospitals list specialties on their websites. People with complex or severe medical conditions may want a rehab hospital connected to an academic medical center at the vanguard of new treatments, even if it's a plane ride away.
Want all of The Times? Subscribe.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
36 minutes ago
- Medscape
Can GERD Increase Colonic Neoplasia Risk?
TOPLINE: An analysis of older adults revealed that subtypes of gastroesophageal reflux disease (GERD) such as erosive esophagitis, nonerosive reflux disease, and Barrett esophagus were associated with an increased risk for colonic neoplasia, with the risk more pronounced for colon polyps than for colorectal cancer. METHODOLOGY: In symptomatic GERD, patients are commonly treated with long-term antisecretory therapy to suppress gastric acid production; however, sustained acid inhibition may undermine the stomach's natural microbial barrier, permit oropharyngeal bacteria to colonize the lower gut, and thereby contribute to the development of colonic neoplasms such as polyps and colorectal cancer. Researchers conducted this case-control study to assess the associations between colon polyps or colorectal cancer and various subtypes of GERD. They analyzed Medicare data of 6,462,321 patients (mean age, 74.6 years; 53.9% women) who presented with erosive esophagitis (n = 74,938), nonerosive reflux disease (n = 1,960,409), Barrett esophagus (n = 51,099), or eosinophilic esophagitis (n = 834). These patients were compared with Medicare patients without GERD. TAKEAWAY: Compared with not having GERD, having erosive esophagitis, Barrett esophagus, or nonerosive reflux disease was associated with significantly higher odds for colon polyps, with adjusted odds ratios [aOR] ranging from 1.70 to 3.96. The association between GERD and colorectal cancer was attenuated but still significant, with aORs ranging from 1.05 to 1.24. In contrast, having eosinophilic esophagitis showed a significant association with colon polyps (aOR, 3.52) but not with colorectal cancer. IN PRACTICE: 'These findings lend support to the hypothesis that long-term use of antisecretory medications may constitute a risk for developing colon neoplasms,' the authors of the study wrote. SOURCE: This study was led by Amnon Sonnenberg, MD, Division of Gastroenterology and Hepatology, Oregon Health & Science University, Portland, Oregon. It was published online in Alimentary Pharmacology & Therapeutics. LIMITATIONS: The study was limited to Medicare beneficiaries older than 65 years. Researchers had no data on obesity, smoking, or other potential confounders. Additionally, the analysis was limited by the absence of pharmacologic data, particularly regarding the effects of various antisecretory medications over prolonged periods. DISCLOSURES: No funding was reported for this study. The authors reported having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Associated Press
2 hours ago
- Associated Press
Stop Gas Station Heroin Coalition Commends FDA Crackdown on Illegal Drug '7'
Agency enforcement targets lab-made analogs, protecting consumers from unapproved new drugs The Stop Gas Station Heroin coalition today commended the U.S. Food and Drug Administration (FDA) for issuing warning letters to companies marketing '7" — a dangerous semi-synthetic alkaloid often disguised as a natural dietary supplement. This action marks a critical step toward curbing the spread of " Gas Station Heroin " — a term used to describe a range of often imported lab-made substances that include tianeptine, nitrous oxide, semi-synthetic and synthetic alkaloid products, and intoxicating hemp products. 7-hydroxymitragynine (7-OH) is only naturally present in trace amounts in dried kratom leaves. Bad actors synthetically mass produce high-concentration, ultra-potent 7-OH isolates in tablets, capsules, powders, and gummies. These chemically manipulated products are misleadingly marketed as natural dietary supplements or food. In reality, they act like prescription opioids and not botanicals, posing serious health risks such as respiratory depression, addiction, and overdose. The FDA's warning letters underscore what scientists and public health experts have long known: Gas Station Heroin products are not supplements. They are unapproved, mislabeled street drugs designed to mimic the effects of opioids and other narcotics. As the FDA notes, Gas Station Heroin products are often aggressively advertised online and in retail locations with deceptive claims about their safety and effectiveness, particularly to individuals seeking to get high or prescription alternatives for pain relief, anxiety, or opioid withdrawal. Stop Gas Station Heroin applauds the FDA for using its enforcement authority to hold these illicit companies accountable and to protect American consumers from the growing threat posed by synthetic drugs. About Stop Gas Station Heroin Stop Gas Station Heroin is a national coalition that aims to educate consumers about harmful synthetic drugs and advocate for smart regulation that distinguishes between legitimate, natural botanicals and dangerous, synthetic drugs, combined with enforcement of current federal laws around unapproved drugs. To learn more, navigate to Media Contact Colby Wilson [email protected] ### SOURCE: Stop Gas Station Heroin Copyright 2025 EZ Newswire

Associated Press
2 hours ago
- Associated Press
Dr. Stephen Courtney Performs World's First Procedure Using Eminent Spine's Groundbreaking 3D-Printed Pedicle Screw
Plano, TX July 16, 2025 --( )-- Eminent Spine, a leading innovator in spinal implant technologies, is proud to announce a major surgical milestone: Dr. Stephen Courtney has successfully completed the world's first spinal procedure using the company's revolutionary 3D-printed pedicle screw system. This groundbreaking case marks a new era in spinal surgery, combining precision engineering with advanced additive manufacturing. Dr. Courtney, a board-certified orthopedic spine surgeon and founder of Eminent Spine, performed the historic procedure at Eminent Hospital in Richardson, Texas. Known for his commitment to innovation and patient outcomes, Dr. Courtney utilized the new 3D pedicle screw system to treat a patient with degenerative lumbar pathology requiring spinal stabilization. The 3D-printed screw, designed and manufactured by Eminent Spine, is the first of its kind to enter clinical use. Built using proprietary lattice technology, the screw optimizes bone ingrowth, enhances mechanical stability, and improves fixation in both normal and compromised bone quality. This next-generation implant represents a leap forward in spinal hardware by improving osseointegration while reducing the potential for loosening or migration over time. This implant truly is the Future of Fusion. Eminent Spine's 3D screw is part of a broader portfolio expansion that includes innovative solutions across the cervical, thoracolumbar, and sacroiliac (SI) regions. With FDA clearance and full commercialization underway, the company expects growing surgeon adoption across the U.S. For more information about Eminent Spine and its new 3D-printed pedicle screw system, visit or email [email protected]. About Eminent Spine: Eminent Spine is a privately held medical device company committed to delivering innovative, cost-effective spinal implant solutions. Founded by spine surgeons, the company designs its products with a deep understanding of both surgical challenges and patient needs. Contact Information: Eminent Spine Dagen Hybner 972-499-3593 Contact via Email For distribution information contact Michael McDonough: [email protected] Read the full story here: Dr. Stephen Courtney Performs World's First Procedure Using Eminent Spine's Groundbreaking 3D-Printed Pedicle Screw Press Release Distributed by